Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -11.75% vs 6.00% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 5.75% vs -8.65% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -2.56% vs -8.53% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -22.32% vs -7.22% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Ben Tre Pharmaceutical JSC With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -27.22% vs 50.82% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -11.75% vs 6.00% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -93.78% vs 367.68% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 5.75% vs -8.65% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -54.98% vs 58.06% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -2.56% vs -8.53% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -25.06% vs -0.07% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -22.32% vs -7.22% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






